List of Oncology Medication For

Autoimmune

ANDEMBRY (garadacimab-gxii) injection

ANDEMBRY (garadacimab-gxii) is a monoclonal antibody prescription medication used as preventive maintenance to stop sudden, severe swelling attacks in adults and children aged 12 and older who have hereditary angioedema (HAE). Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Brand Name:	ANDEMBRY
Generic Name:	garadacimab-gxii injection
Strength:	Injection: • 200 mg/1.2 mL solution in single-dose prefilled autoinjector (3) • 200 mg/1.2 mL (167 mg/mL) solution in single-dose prefilled syringe with needle safety device
Manufacturer:	CSL Behring
Approved By:	EMA, USFDA

Source Details: Patient Information.

ANDEMBRY must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access ANDEMBRY for hereditary angioedema (HAE) on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ANDEMBRY (garadacimab-gxii) injection for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

DECNUPAZ (pivekimab sunirine-pvzy) for injection

Autoimmune

DECNUPAZ is a prescription medicine used to treat adults with blastic plasmacytoid dendritic cell neoplasm (BPDCN). It is not known if DECNUPAZ is safe and effective in children. Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Brand Name:	DECNUPAZ
Generic Name:	pivekimab sunirine-pvzy for injection
Strength:	For injection: 2 mg of pivekimab sunirine-pvzy as a lyophilized cake in a single-dose vial
Manufacturer:	AbbVie Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information.

DECNUPAZ must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access DECNUPAZ for BPDCN on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to DECNUPAZ (pivekimab sunirine-pvzy) for injection for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

EXDENSUR (depemokimab-ulaa) injection

Autoimmune

EXDENSUR (depemokimab) is an ultra-long-acting biologic prescription medication used for the add-on maintenance treatment of severe eosinophilic asthma in adults and children aged 12 and older. It helps prevent severe asthma attacks but is not a rescue treatment for sudden breathing problems or acute asthma attacks. Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Brand Name:	EXDENSUR
Generic Name:	depemokimab-ulaa injection
Strength:	Injection: • 100 mg/mL solution in a single-dose, prefilled pen • 100 mg/mL solution in a single-dose, prefilled syringe with needle guard
Manufacturer:	GlaxoSmithKline
Approved By:	EMA, USFDA

Source Details: Patient Information.

EXDENSUR must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access EXDENSUR for asthma on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to EXDENSUR (depemokimab-ulaa) injection for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

Icotyde (icotrokinra) Tablets

Autoimmune

ICOTYDE™ (icotrokinra) was approved by the US FDA in March 2026 for the treatment of moderate-to-severe PsO. Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Therapy Class: Interleukin-23 (IL-23) receptor antagonist
Current Indication: Moderate-to-severe plaque psoriasis
Market Sector: Dermatology

Brand Name:	Icotyde
Generic Name:	icotrokinra Tablets
Strength:	Tablets: 200 mg
Manufacturer:	Johnson & Johnson
Approved By:	EMA, USFDA

Source Details: Patient Information.

Icotyde must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access Icotyde for Dermatology on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Icotyde (icotrokinra) Tablets for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

IMAAVY (nipocalimab-aahu) injection

Autoimmune

Imaavy (nipocalimab-Aahu) Is a Monoclonal Antibody Approved for The Treatment of Generalized Myasthenia Gravis (g Mg). Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Brand Name:	IMAAVY
Generic Name:	nipocalimab-aahu injection
Strength:	Injection: 300 mg/1.62 mL (185 mg/mL) in a single-dose vial (3) • Injection: 1,200 mg/6.5 mL (185 mg/mL) in a single-dose vial (3)
Manufacturer:	Janssen Biotech, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information.

IMAAVY must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access IMAAVY for Generalized Myasthenia Gravis (g Mg) on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to IMAAVY (nipocalimab-aahu) injection for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

Lynozyfic (Linvoseltamab) Injection

Autoimmune

Lynozyfic (generic name linvoseltamab-gcpt) is a prescription immunotherapy used to treat adults with relapsed or refractory multiple myeloma (a bone marrow cancer). Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Brand Name:	Lynozyfic
Generic Name:	Linvoseltamab Injection
Strength:	The active substance is linvoseltamab. • Each vial contains 5 mg of linvoseltamab in 2.5 mL (2 mg/mL). • Each vial contains 200 mg of linvoseltamab in 10 mL (20 mg/mL). The other ingredients are histidine, histidine hydrochloride monohydrate, sucrose, pol
Manufacturer:	Regeneron Ireland DAC
Approved By:	EMA, USFDA

Source Details: Patient Information.

Lynozyfic must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access Lynozyfic for multiple myeloma on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Lynozyfic (Linvoseltamab) Injection for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

Sacituzumab Govitecan-HZIY for Injection

Breast Cancer, Autoimmune, Gastrointestinal

Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

Sacituzumab govitecan-hziy for injection is a “used to treat Urothelial Carcinoma, Breast Cancer“. TRODELVY for injection is a “prescription medicine. It is available in “form and strength” For injection: 180 mg lyophilized powder in single-dose vials for reconstitution.. TRODELVY for injection can be obtained in India upon request.

Facts about your medicine

Name: TRODELVY
Active substance: sacituzumab govitecan-hziy
Disease Indications-Urothelial Carcinoma, Breast Cancer
Manufacturer-Immunomedics Inc.
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here for TRODELVY usage
(see Drugs@FDA for complete indication)

Access the best support services globally

IPN, New Delhi can facilitate patient to import of “sacituzumab govitecan-hziy for injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

TRODELVY (sacituzumab govitecan-hziy) for injection

Breast Cancer, Autoimmune

Brand Name: TRODELVY Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

TRODELVY is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.

Brand Name:	TRODELVY
Generic Name:	sacituzumab govitecan-hziy
Strength:	• For injection: 180 mg lyophilized powder in single-dose vials for reconstitution.
Manufacturer:	Gilead Sciences, Inc.
Approved By:	EMA, USFDA

Source content : www.accessdata.fda.gov

IPN, New Delhi can facilitate patient to import of “TRODELVY (sacituzumab govitecan-hziy) for injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

ZILBRYSQ (zilucoplan) Injection

Immune, Autoimmune

Brand Name: ZILBRYSQ Generic Name: (zilucoplan)
ZILBRYSQ (zilucoplan) is used to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive.

ZILBRYSQ is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive..

Brand Name:	ZILBRYSQ
Generic Name:	zilucoplan
Strength:	Injection: 16.6 mg/0.416 mL, 23 mg/0.574 mL, or 32.4 mg/0.81 mL zilucoplan in single-dose prefilled syringes.
Manufacturer:	UCB, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “ZILBRYSQ (zilucoplan)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for ZILBRYSQ (zilucoplan) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Autoimmune

ANDEMBRY (garadacimab-gxii) injection

Access ANDEMBRY for hereditary angioedema (HAE) on a Named Patient Import Basis

DECNUPAZ (pivekimab sunirine-pvzy) for injection

Access DECNUPAZ for BPDCN on a Named Patient Import Basis

EXDENSUR (depemokimab-ulaa) injection

Access EXDENSUR for asthma on a Named Patient Import Basis

Icotyde (icotrokinra) Tablets

Access Icotyde for Dermatology on a Named Patient Import Basis

IMAAVY (nipocalimab-aahu) injection

Access IMAAVY for Generalized Myasthenia Gravis (g Mg) on a Named Patient Import Basis

Lynozyfic (Linvoseltamab) Injection

Access Lynozyfic for multiple myeloma on a Named Patient Import Basis

Sacituzumab Govitecan-HZIY for Injection

Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

Facts about your medicine

Access the best support services globally

TRODELVY (sacituzumab govitecan-hziy) for injection

Brand Name: TRODELVY Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

ZILBRYSQ (zilucoplan) Injection

Brand Name: ZILBRYSQ Generic Name: (zilucoplan)
ZILBRYSQ (zilucoplan) is used to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive.

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

Company

Drugs Approved for

Gastroenterology

Hematology

Drugs Approved For

Autoimmune

Access ANDEMBRY for hereditary angioedema (HAE) on a Named Patient Import Basis

Access DECNUPAZ for BPDCN on a Named Patient Import Basis

Access EXDENSUR for asthma on a Named Patient Import Basis

Access Icotyde for Dermatology on a Named Patient Import Basis

Access IMAAVY for Generalized Myasthenia Gravis (g Mg) on a Named Patient Import Basis

Access Lynozyfic for multiple myeloma on a Named Patient Import Basis

Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

Facts about your medicine

Access the best support services globally

Brand Name: TRODELVY Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

Brand Name: ZILBRYSQ Generic Name: (zilucoplan) ZILBRYSQ (zilucoplan) is used to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive.

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

Brand Name: ZILBRYSQ Generic Name: (zilucoplan)
ZILBRYSQ (zilucoplan) is used to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive.